CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 20 enrolled
Drug / intervention
Nitric Oxide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02871011
NCT02871011Phase 2Completed
CompareCT.gov

A Blinded Placebo Controlled Clinical Trial To Evaluate Fungicidal Activity With The Topical Application Of Nitric Oxide Releasing Solution (Nors) In Subjects With Moderate To Severe Tinea Pedis (Athlete's Foot)

Nitric Solutions Inc.·interventional·Posted Aug 18, 2016·Updated Sep 20, 2019

In Brief

A Phase 2 clinical trial evaluating Nitric Oxide and Water for Tinea Pedis. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this study is to determine the fungicidal efficacy of nitric oxide releasing solution footbath and it's effect on the clinical signs and symptoms associated with Tinea Pedis

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsTinea Pedis
CountriesCanada
Collaborators--

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedAug 18, 2016
Enrollment StartAug 13, 2016
Primary CompletionNov 14, 2016
Study CompletionFeb 21, 2017
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 9.9 years ago

Interventions

Nitric Oxidedrug

Delivered as a footbath

Waterdrug

Delivered as a footbath